<p>杜比实验室（NYSE:DLB - 获取免费报告）在周二的盘中交易中股价创下 52 周新低。该公司股价最低跌至 55.11 美元，最后交易价格为 55.5180 美元，成交量为 572340 股。该股票此前收盘价为 57.59 美元。</p>
<p>获取 <strong>杜比实验室</strong> 的提醒：</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>大屏幕股票因第二季度强劲财报飙升</li>
</ul>
<p>多家股票研究分析师最近对该公司发布了报告。Weiss Ratings 在 3 月 27 日的研究报告中重新发布了对杜比实验室股票的 “持有（c-）” 评级。Wall Street Zen 在 1 月 31 日的研究报告中将杜比实验室的评级从 “买入” 下调至 “持有”。Rosenblatt Securities 在 1 月 30 日的报告中重申了 “买入” 评级，并对杜比实验室的股票设定了 85.00 美元的目标价。最后，Barrington Research 在 4 月 27 日的报告中重申了 “跑赢大盘” 评级，并对杜比实验室的股票设定了 90.00 美元的目标价。三位研究分析师对该股票给予了 “买入” 评级，两位分析师对该公司的股票给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 90.75 美元。</p>
<p><strong>获取我们对 DLB 的最新分析</strong></p>
<h2>杜比实验室股价下跌 3.7%</h2>
<p>该公司的市值为 52.5 亿美元，市盈率为 21.92，贝塔值为 0.86。该股票的 50 日移动平均价格为 61.96 美元，200 日移动平均价格为 64.11 美元。</p>
<p>杜比实验室（NYSE:DLB - 获取免费报告）最后一次公布财报是在 4 月 30 日，电子制造商报告本季度每股收益（EPS）为 1.37 美元，超出市场共识预期的 1.31 美元，超出 0.06 美元。该业务在本季度的收入为 3.9563 亿美元，而分析师预期为 3.8580 亿美元。杜比实验室的股本回报率为 11.47%，净利润率为 17.85%。与去年同期相比，杜比实验室本季度的收入增长了 7.0%。去年同期，该公司每股收益为 1.34 美元。杜比实验室已将其 2026 财年的指引设定为每股收益 4.300-4.450 美元，2026 年第三季度的指引设定为每股收益 0.560-0.710 美元。研究分析师平均预测杜比实验室今年将发布 3.22 美元的每股收益。</p>
<h2>杜比实验室分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 5 月 20 日（星期三）支付。5 月 12 日（星期二）的登记投资者将获得每股 0.36 美元的分红。这代表着每年 1.44 美元的分红和 2.6% 的收益率。该分红的除息日为 5 月 12 日（星期二）。杜比实验室的分红支付比率（DPR）目前为 56.92%。</p>
<h2>内部买卖</h2>
<p>在相关消息中，SVP Shriram Revankar 在 2 月 17 日（星期二）以 66.14 美元的平均价格出售了 3000 股该公司的股票，总交易额为 198,420.00 美元。交易完成后，该高级副总裁直接持有该公司 83,218 股股票，价值 5,504,038.52 美元。此交易代表其持股比例减少了 3.48%。该出售在向证券交易委员会提交的文件中披露，文件可在此链接查看。此外，SVP John D. Couling 在 5 月 5 日（星期二）以 57.55 美元的平均价格出售了 7,666 股该股票，总价值为 441,178.30 美元。出售后，该高级副总裁持有 118,353 股该公司的股票，价值约为 6,811,215.15 美元。该交易使其持股比例减少了 6.08%。有关此出售的更多细节可在官方 SEC 披露中找到。内部人士在过去三个月内共出售了价值 1,090,741 美元的 18,021 股公司股票。内部人士持有该公司 37.93% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>多家对冲基金最近对其在 DLB 的持仓进行了调整。加拿大皇家银行在第一季度将其在杜比实验室的持仓增加了 3.5%。加拿大皇家银行目前持有 68,367 股该电子制造商的股票，价值 5,491,000 美元，此前在上个季度增持了 2,298 股。高盛集团在第一季度将其在杜比实验室的持仓增加了 218.8%。高盛集团目前持有 249,574 股该电子制造商的股票，价值 20,043,000 美元，此前在上个季度增持了 171,288 股。瑞银资产管理公司旗下的一个独立业务单位在第一季度将其在杜比实验室的持仓增加了 5.6%。瑞银资产管理公司目前持有 238,216 股该电子制造商的股票，价值 19,131,000 美元，此前在上个季度增持了 12,598 股。Focus Partners Wealth 在第一季度新购入了价值 390,000 美元的杜比实验室股份。最后，EverSource Wealth Advisors LLC 在第二季度将其在杜比实验室的持仓增加了 273.3%。EverSource Wealth Advisors LLC 目前持有 2,598 股该电子制造商的股票，价值 193,000 美元，此前在上个季度增持了 1,902 股。目前 58.56% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>杜比实验室公司简介</h2>
<p>（获取免费报告）</p>
<p>杜比实验室公司是一家全球领先的音频和影像技术公司，专注于开发、许可和部署增强娱乐和通信体验的解决方案。公司的核心业务围绕创建先进的音频编解码器、降噪系统和空间音效技术，适用于包括影院、广播、游戏、流媒体和个人设备在内的广泛应用。杜比的许可模式使消费电子制造商、内容创作者和服务提供商能够将其技术集成到电视、智能手机、家庭影院系统和机顶盒等产品中。</p>
<p>其旗舰创新包括杜比全景声（Dolby Atmos），一种沉浸式音频格式，为影院和家庭系统提供三维音效；杜比数字（Dolby Digital）和杜比数字增强版（Dolby Digital Plus），广泛采用的广播和流媒体音频压缩格式；以及杜比视界（Dolby Vision），一种高动态范围成像技术，扩展显示器的色彩、对比度和亮度。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过杜比实验室</li>
<li>AST SpaceMobile 因银河第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
<li>Hims &amp; Hers 股票在第一季度业绩不佳后暴跌：GLP-1 的转变足以推动复苏吗？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在杜比实验室吗？</h2>
<p>在考虑杜比实验室之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而杜比实验室并不在名单上。</p>
<p>虽然杜比实验室目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

杜比实验室

<p>杜比实验室（NYSE:DLB）创下 52 周新低，报$55.11，收盘价为$55.5180，交易量为 572,340 股。分析师的评级意见不一，三位分析师推荐买入，二位分析师建议持有。该公司报告第一季度每股收益为$1.37，超出预期，营收同比增长 7%。杜比宣布每股季度分红为$0.36，收益率为 2.6%。内部人士进行了股票出售，近期有大量股份被出售。对冲基金也调整了在该公司的持仓，加拿大皇家银行和高盛的持仓显著增加</p>

<p>Dolby Laboratories (NYSE:DLB - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $55.11 and last traded at $55.5180, with a volume of 572340 shares. The stock had previously closed at $57.59.</p>
<div class="lb-trans"><p>杜比实验室（NYSE:DLB - 获取免费报告）在周二的盘中交易中股价创下 52 周新低。该公司股价最低跌至 55.11 美元，最后交易价格为 55.5180 美元，成交量为 572340 股。该股票此前收盘价为 57.59 美元。</p>
</div><p>Get <strong>Dolby Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>杜比实验室</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Big Screen Stock Soars on Blockbuster Q2 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>大屏幕股票因第二季度强劲财报飙升</li>
</ul>
</div><p>A number of equities research analysts recently issued reports on the company. Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Wall Street Zen downgraded Dolby Laboratories from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, January 31st. Rosenblatt Securities reaffirmed a &#34;buy&#34; rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, January 30th. Finally, Barrington Research reaffirmed an &#34;outperform&#34; rating and issued a $90.00 target price on shares of Dolby Laboratories in a report on Monday, April 27th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $90.75.</p>
<div class="lb-trans"><p>多家股票研究分析师最近对该公司发布了报告。Weiss Ratings 在 3 月 27 日的研究报告中重新发布了对杜比实验室股票的 “持有（c-）” 评级。Wall Street Zen 在 1 月 31 日的研究报告中将杜比实验室的评级从 “买入” 下调至 “持有”。Rosenblatt Securities 在 1 月 30 日的报告中重申了 “买入” 评级，并对杜比实验室的股票设定了 85.00 美元的目标价。最后，Barrington Research 在 4 月 27 日的报告中重申了 “跑赢大盘” 评级，并对杜比实验室的股票设定了 90.00 美元的目标价。三位研究分析师对该股票给予了 “买入” 评级，两位分析师对该公司的股票给予了 “持有” 评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 90.75 美元。</p>
</div><p><strong>Get Our Latest Analysis on DLB</strong></p>
<div class="lb-trans"><p><strong>获取我们对 DLB 的最新分析</strong></p>
</div><h2>Dolby Laboratories Trading Down 3.7%</h2>
<div class="lb-trans"><h2>杜比实验室股价下跌 3.7%</h2>
</div><p>The company has a market capitalization of $5.25 billion, a P/E ratio of 21.92 and a beta of 0.86. The stock has a 50 day moving average price of $61.96 and a 200 day moving average price of $64.11.</p>
<div class="lb-trans"><p>该公司的市值为 52.5 亿美元，市盈率为 21.92，贝塔值为 0.86。该股票的 50 日移动平均价格为 61.96 美元，200 日移动平均价格为 64.11 美元。</p>
</div><p>Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.Dolby Laboratories's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts predict that Dolby Laboratories will post 3.22 EPS for the current year.</p>
<div class="lb-trans"><p>杜比实验室（NYSE:DLB - 获取免费报告）最后一次公布财报是在 4 月 30 日，电子制造商报告本季度每股收益（EPS）为 1.37 美元，超出市场共识预期的 1.31 美元，超出 0.06 美元。该业务在本季度的收入为 3.9563 亿美元，而分析师预期为 3.8580 亿美元。杜比实验室的股本回报率为 11.47%，净利润率为 17.85%。与去年同期相比，杜比实验室本季度的收入增长了 7.0%。去年同期，该公司每股收益为 1.34 美元。杜比实验室已将其 2026 财年的指引设定为每股收益 4.300-4.450 美元，2026 年第三季度的指引设定为每股收益 0.560-0.710 美元。研究分析师平均预测杜比实验室今年将发布 3.22 美元的每股收益。</p>
</div><h2>Dolby Laboratories Dividend Announcement</h2>
<div class="lb-trans"><h2>杜比实验室分红公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, May 12th. Dolby Laboratories's dividend payout ratio (DPR) is currently 56.92%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 5 月 20 日（星期三）支付。5 月 12 日（星期二）的登记投资者将获得每股 0.36 美元的分红。这代表着每年 1.44 美元的分红和 2.6% 的收益率。该分红的除息日为 5 月 12 日（星期二）。杜比实验室的分红支付比率（DPR）目前为 56.92%。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In related news, SVP Shriram Revankar sold 3,000 shares of the firm's stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $66.14, for a total transaction of $198,420.00. Following the completion of the transaction, the senior vice president directly owned 83,218 shares of the company's stock, valued at $5,504,038.52. This trade represents a 3.48% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $57.55, for a total value of $441,178.30. Following the sale, the senior vice president owned 118,353 shares of the company's stock, valued at approximately $6,811,215.15. The trade was a 6.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 18,021 shares of company stock valued at $1,090,741 in the last three months. Insiders own 37.93% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，SVP Shriram Revankar 在 2 月 17 日（星期二）以 66.14 美元的平均价格出售了 3000 股该公司的股票，总交易额为 198,420.00 美元。交易完成后，该高级副总裁直接持有该公司 83,218 股股票，价值 5,504,038.52 美元。此交易代表其持股比例减少了 3.48%。该出售在向证券交易委员会提交的文件中披露，文件可在此链接查看。此外，SVP John D. Couling 在 5 月 5 日（星期二）以 57.55 美元的平均价格出售了 7,666 股该股票，总价值为 441,178.30 美元。出售后，该高级副总裁持有 118,353 股该公司的股票，价值约为 6,811,215.15 美元。该交易使其持股比例减少了 6.08%。有关此出售的更多细节可在官方 SEC 披露中找到。内部人士在过去三个月内共出售了价值 1,090,741 美元的 18,021 股公司股票。内部人士持有该公司 37.93% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds have recently made changes to their positions in DLB. Royal Bank of Canada grew its position in Dolby Laboratories by 3.5% in the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker's stock worth $5,491,000 after acquiring an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in Dolby Laboratories by 218.8% in the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker's stock worth $20,043,000 after purchasing an additional 171,288 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Dolby Laboratories by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker's stock worth $19,131,000 after purchasing an additional 12,598 shares during the last quarter. Focus Partners Wealth bought a new stake in Dolby Laboratories in the first quarter worth $390,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Dolby Laboratories by 273.3% in the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker's stock worth $193,000 after purchasing an additional 1,902 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>多家对冲基金最近对其在 DLB 的持仓进行了调整。加拿大皇家银行在第一季度将其在杜比实验室的持仓增加了 3.5%。加拿大皇家银行目前持有 68,367 股该电子制造商的股票，价值 5,491,000 美元，此前在上个季度增持了 2,298 股。高盛集团在第一季度将其在杜比实验室的持仓增加了 218.8%。高盛集团目前持有 249,574 股该电子制造商的股票，价值 20,043,000 美元，此前在上个季度增持了 171,288 股。瑞银资产管理公司旗下的一个独立业务单位在第一季度将其在杜比实验室的持仓增加了 5.6%。瑞银资产管理公司目前持有 238,216 股该电子制造商的股票，价值 19,131,000 美元，此前在上个季度增持了 12,598 股。Focus Partners Wealth 在第一季度新购入了价值 390,000 美元的杜比实验室股份。最后，EverSource Wealth Advisors LLC 在第二季度将其在杜比实验室的持仓增加了 273.3%。EverSource Wealth Advisors LLC 目前持有 2,598 股该电子制造商的股票，价值 193,000 美元，此前在上个季度增持了 1,902 股。目前 58.56% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Dolby Laboratories Company Profile</h2>
<div class="lb-trans"><h2>杜比实验室公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.</p>
<div class="lb-trans"><p>杜比实验室公司是一家全球领先的音频和影像技术公司，专注于开发、许可和部署增强娱乐和通信体验的解决方案。公司的核心业务围绕创建先进的音频编解码器、降噪系统和空间音效技术，适用于包括影院、广播、游戏、流媒体和个人设备在内的广泛应用。杜比的许可模式使消费电子制造商、内容创作者和服务提供商能够将其技术集成到电视、智能手机、家庭影院系统和机顶盒等产品中。</p>
</div><p>Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.</p>
<div class="lb-trans"><p>其旗舰创新包括杜比全景声（Dolby Atmos），一种沉浸式音频格式，为影院和家庭系统提供三维音效；杜比数字（Dolby Digital）和杜比数字增强版（Dolby Digital Plus），广泛采用的广播和流媒体音频压缩格式；以及杜比视界（Dolby Vision），一种高动态范围成像技术，扩展显示器的色彩、对比度和亮度。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Dolby Laboratories</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
<li>Hims &amp; Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过杜比实验室</li>
<li>AST SpaceMobile 因银河第一季度业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
<li>Hims &amp; Hers 股票在第一季度业绩不佳后暴跌：GLP-1 的转变足以推动复苏吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Dolby Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在杜比实验室吗？</h2>
</div><p>Before you consider Dolby Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑杜比实验室之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而杜比实验室并不在名单上。</p>
</div><p>While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然杜比实验室目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

杜比实验室（NYSE:DLB）创下 12 个月新低 - 你是否应该卖出？